96 related articles for article (PubMed ID: 17261412)
1. Cypher versus Taxus: all smoke and no fire: lessons for future comparative drug-eluting stent trials in interventional cardiology.
Buch AN; Waksman R
Am J Cardiol; 2007 Feb; 99(3):424-7. PubMed ID: 17261412
[No Abstract] [Full Text] [Related]
2. Drug eluting stents for everyone and everything?
Laham RJ
Catheter Cardiovasc Interv; 2005 Dec; 66(4):512-3. PubMed ID: 16270362
[No Abstract] [Full Text] [Related]
3. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
[TBL] [Abstract][Full Text] [Related]
4. Benefits of drug-eluting stents in coronary heart disease treatment with emphasis on the diabetic subgroup.
Nguyen MC; Lim YL
Heart Lung Circ; 2007 Feb; 16(1):7-9. PubMed ID: 17169611
[No Abstract] [Full Text] [Related]
5. Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI).
Escolar E; Mintz GS; Popma J; Michalek A; Kim SW; Mandinov L; Koglin J; Stone G; Ellis SG; Grube E; Dawkins KD; Weissman NJ
Am J Cardiol; 2007 Aug; 100(4):621-6. PubMed ID: 17697817
[TBL] [Abstract][Full Text] [Related]
6. Overview: drug eluting stents.
Dauerman HL
Coron Artery Dis; 2006 Dec; 17(8):657-9. PubMed ID: 17119372
[No Abstract] [Full Text] [Related]
7. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus-eluting stents. (The results of the five-year use for the treatment of coronary artery disease).
Krylov AL
Angiol Sosud Khir; 2006; 12(4):71-82. PubMed ID: 17679960
[TBL] [Abstract][Full Text] [Related]
9. New drug-eluting stent platforms to prevent stent thrombosis.
Kereiakes DJ
Rev Cardiovasc Med; 2007; 8 Suppl 1():S34-43. PubMed ID: 17401310
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
[TBL] [Abstract][Full Text] [Related]
11. Carotid artery in-stent restenosis resolved with drug-eluting stenting.
Iancu A; Lazar A
J Invasive Cardiol; 2007 Jul; 19(7):315. PubMed ID: 17620678
[No Abstract] [Full Text] [Related]
12. [Paclitaxel-eluting stents in treatment of stenoses and chronic occlusions of coronary arteries].
Maslov LN; Krylov AL
Angiol Sosud Khir; 2007; 13(3):53-60. PubMed ID: 18382394
[TBL] [Abstract][Full Text] [Related]
13. Risk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials.
Sanchez-Recalde A; Moreno R; Barreales L; Rivero F; Galeote G; Jimenez-Valero S; Calvo L; López de Sá E; López-Sendón JL
J Invasive Cardiol; 2008 Aug; 20(8):417-22. PubMed ID: 18688067
[TBL] [Abstract][Full Text] [Related]
14. Use of SafeCut Balloon for treatment of in-stent restenosis of a previously underexpanded sirolimus-eluting stent with a heavily calcified plaque.
Otsuka Y; Kasahara Y; Kawamura A
J Invasive Cardiol; 2007 Dec; 19(12):E359-62. PubMed ID: 18180527
[TBL] [Abstract][Full Text] [Related]
15. Very late drug-eluting stent thrombosis and cardiogenic shock: 1,249 days after implantation.
Chen JP
J Invasive Cardiol; 2007 Dec; 19(12):E381-4. PubMed ID: 18180534
[TBL] [Abstract][Full Text] [Related]
16. Incidence of late stent thrombosis with bare-metal, sirolimus, and paclitaxel stents.
Holmes DR
Rev Cardiovasc Med; 2007; 8 Suppl 1():S11-8. PubMed ID: 17401306
[TBL] [Abstract][Full Text] [Related]
17. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents: current issues.
Ong AT; Serruys PW
Tex Heart Inst J; 2005; 32(3):372-7. PubMed ID: 16392222
[TBL] [Abstract][Full Text] [Related]
19. Promise and challenges of bioabsorbable stents.
Waksman R
Catheter Cardiovasc Interv; 2007 Sep; 70(3):407-14. PubMed ID: 17722019
[TBL] [Abstract][Full Text] [Related]
20. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
